Name | Danicopan |
---|
Description | Danicopan, a selective and orally active small-molecule factor D inhibitor, inhibits alternative pathway of complement (APC) activity. Danicopan has potential to block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)[1]. |
---|---|
Related Catalog | |
Target |
Factor D[1] |
References |
Molecular Formula | C26H23BrFN7O3 |
---|---|
Molecular Weight | 580.41 |